Keyword: Pearl

News

Pascal Soriot: AstraZeneca Turnaround is 3-4 Year Journey

19.06.2013 - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief...

News

AstraZeneca Buys U.S. Lung Drug Firm Pearl for up to $1.15 Billion

10.06.2013 - AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion as Britain's second biggest drugmaker steps up a drive to rebuild its product...

News

Shell Under the Skin, 10 Years After Crisis

30.05.2013 - A decade ago, Royal Dutch/Shell's boss was fighting to close the gap between the truth about his company's oil and gas reserves and the much larger figure in its accounts. He lost...